CAR-T cell therapy: a potential new strategy against prostate cancer

Prostate cancer (PCa) is one of the main causes of cancer-related death in men. In the present immunotherapy era, several immunotherapeutic agents have been evaluated in PCa with poor results, possibly due to its low mutational burden. The recent development of chimeric antigen receptor (CAR)-T cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Schepisi, Giuseppe, Cursano, Maria Concetta, Casadei, Chiara, Menna, Cecilia, Altavilla, Amelia, Lolli, Cristian, Cerchione, Claudio, Paganelli, Giovanni, Santini, Daniele, Tonini, Giuseppe, Martinelli, Giovanni, De Giorgi, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794851/
https://www.ncbi.nlm.nih.gov/pubmed/31619289
http://dx.doi.org/10.1186/s40425-019-0741-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794851/
https://www.ncbi.nlm.nih.gov/pubmed/31619289
http://dx.doi.org/10.1186/s40425-019-0741-7

Ejemplares similares